Goldman Sachs’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.26M | Buy |
|
|||||
|
2025
Q2 | $259K | Sell |
|
|||||
|
2025
Q1 | $248K | Sell |
|
|||||
|
2024
Q4 | $870K | Sell |
|
|||||
|
2024
Q3 | $1.73M | Buy |
|
|||||
|
2024
Q2 | $475K | Sell |
|
|||||
|
2024
Q1 | $3.77M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $10K | Sell |
|
|||||
|
2022
Q2 | $41K | Sell |
|
|||||
|
2022
Q1 | $126K | Buy |
|
|||||
|
2021
Q4 | $222K | Sell |
|
|||||
|
2021
Q3 | $850K | Sell |
|
|||||
|
2021
Q2 | $1.93M | Sell |
|
|||||
|
2021
Q1 | $4.17M | Buy |
|
|||||
|
2020
Q4 | $400K | Buy |
|
|||||
|
2020
Q3 | $131K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.22M | Buy |
|
|||||
|
2019
Q4 | $189K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $77K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $149K | Sell |
|
|||||
|
2017
Q4 | $9.54M | Sell |
|
|||||
|
2017
Q3 | $13.7M | Buy |
|
|||||
|
2017
Q2 | $13.5M | Sell |
|
|||||
|
2017
Q1 | $16.2M | Sell |
|
|||||
|
2016
Q4 | $16M | Sell |
|
|||||
|
2016
Q3 | $13.2M | Buy |
|
|||||
|
2016
Q2 | $6.34M | Sell |
|
|||||
|
2016
Q1 | $8.56M | Buy |
|
|||||
|
2015
Q4 | $225K | Buy |
|